Drugs / exHSC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07031765 | Jul 2025 → Dec 2030 expected | astrocytoma (excluding glioblastoma), ependymoma, high grade astrocytic tumor, oligoastrocytoma +2 | University of Florida | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | exHSC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07031765 ↗ |
| Modality | Cell therapy | “Ex vivo expanded CD34+ hematopoietic stem cells (exHSCs)” NCT07031765 ↗ |